Kyaw Moe H, Chan Francis K L
Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong.
Department of Medicine & Therapeutics, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong.
Gastrointest Endosc Clin N Am. 2018 Jul;28(3):351-361. doi: 10.1016/j.giec.2018.02.007.
The incidence of antithrombotic-associated gastrointestinal (GI) bleeding is increasing due to the growing advanced age population. There is consensus on ceasing anticoagulant and antiplatelet agents during an acute GI bleeding episode but clearer guidance is needed on resumption of these agents. This article reviews evidence for optimal management of antithrombotics in the setting of acute GI bleeding and highlights areas in which future studies are needed.
由于老年人口的不断增加，抗血栓治疗相关的胃肠道（GI）出血的发生率正在上升。在急性胃肠道出血发作期间停用抗凝剂和抗血小板药物已达成共识，但在这些药物的重新使用方面需要更明确的指导。本文回顾了急性胃肠道出血情况下抗血栓药物最佳管理的证据，并强调了未来需要研究的领域。
